TY - JOUR
T1 - Women in Steady Exercise Research (WISER)
T2 - Study design and methods
AU - Arikawa, Andrea Y.
AU - O'Dougherty, Maureen
AU - Kaufman, Beth C.
AU - Smith, Alma J.
AU - Thomas, William
AU - Warren, Meghan
AU - Kurzer, Mindy S.
AU - Schmitz, Kathryn H.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2010/9
Y1 - 2010/9
N2 - Purpose: Observational studies have shown that physical activity is inversely associated with breast cancer etiology. WISER is a randomized controlled trial examining the effects of exercise training on oxidative stress, and hormonal and metabolic factors associated with breast cancer risk. Method: Subjects were recruited via emails, flyers, and mass media advertising. Inclusion criteria included: sedentary, age 18-30 years, non-smokers, BMI 18-40 kg/m2, not using any hormonal contraceptives. After completion of all baseline measures subjects were randomized into a control group or an exercise intervention for 4 menstrual cycles. The exercise group was asked to complete five 45 min exercise sessions per week. Exercise intensity was set at 65-70% of maximum age- predicted heart rate (max HR) and increased every four weeks. All women provided blood samples four times during the study for measurement of blood F2-isoprostanes, hormones and IGF-axis proteins. In addition, 24-hour urine samples were collected at baseline and follow-up for measurement of estrogen metabolites, as well as 24-hour food records to monitor participants' diets. Discussion: WISER consented 683 women among which 391 enrolled and 319 successfully completed the study. The overall dropout rate was 18.4% (n=72) with a higher number of participants dropping from the exercise group (n=46). No differences were found between dropouts and completers with respect to age, body weight, BMI, and demographic characteristics with the exception of degree of education. Findings from this trial will be useful in understanding the physiologic mechanisms by which exercise possibly contibutes to decreased breast cancer risk.
AB - Purpose: Observational studies have shown that physical activity is inversely associated with breast cancer etiology. WISER is a randomized controlled trial examining the effects of exercise training on oxidative stress, and hormonal and metabolic factors associated with breast cancer risk. Method: Subjects were recruited via emails, flyers, and mass media advertising. Inclusion criteria included: sedentary, age 18-30 years, non-smokers, BMI 18-40 kg/m2, not using any hormonal contraceptives. After completion of all baseline measures subjects were randomized into a control group or an exercise intervention for 4 menstrual cycles. The exercise group was asked to complete five 45 min exercise sessions per week. Exercise intensity was set at 65-70% of maximum age- predicted heart rate (max HR) and increased every four weeks. All women provided blood samples four times during the study for measurement of blood F2-isoprostanes, hormones and IGF-axis proteins. In addition, 24-hour urine samples were collected at baseline and follow-up for measurement of estrogen metabolites, as well as 24-hour food records to monitor participants' diets. Discussion: WISER consented 683 women among which 391 enrolled and 319 successfully completed the study. The overall dropout rate was 18.4% (n=72) with a higher number of participants dropping from the exercise group (n=46). No differences were found between dropouts and completers with respect to age, body weight, BMI, and demographic characteristics with the exception of degree of education. Findings from this trial will be useful in understanding the physiologic mechanisms by which exercise possibly contibutes to decreased breast cancer risk.
KW - Aerobic exercise
KW - Breast cancer risk
KW - Estrogens
KW - F2- isoprostanes
KW - IGF
KW - Premenopausal women
KW - Randomized control trial
UR - http://www.scopus.com/inward/record.url?scp=77957751235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957751235&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2010.05.008
DO - 10.1016/j.cct.2010.05.008
M3 - Article
C2 - 20576482
AN - SCOPUS:77957751235
SN - 1551-7144
VL - 31
SP - 457
EP - 465
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
IS - 5
ER -